Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Metagenomi Therapeutics, Inc.: Amended and restated bylaws to eliminate stockholder written consent and special meeting ability, establish advance notice procedures for stockholder proposals and director nominations, and conform to the restated certificate.
- Change
- bylaw amendment
Exact text from the filing
the amended and restated bylaws of the Company (the “Amended and Restated Bylaws”), previously approved by the Board and the Company’s stockholders to become effective immediately upon effectiveness of the Registration Statement, became effective.
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Metagenomi Therapeutics, Inc.: Filed amended and restated certificate of incorporation to authorize 500,000,000 shares of common stock, eliminate references to existing preferred stock, and authorize 10,000,000 shares of undesignated preferred stock.
- Change
- charter amendment
Exact text from the filing
the Company filed an amended and restated certificate of incorporation (the “Restated Certificate”) with the Secretary of State of the State of Delaware.
View on SEC.gov